featured
Biomarker-Driven Therapies for Previously Treated Squamous NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Biomarker-Driven Therapies for Previously Treated Squamous Non-Small-Cell Lung Cancer (Lung-MAP SWOG S1400): A Biomarker-Driven Master Protocol
Lancet Oncol 2020 Oct 27;[EPub Ahead of Print], MW Redman, VA Papadimitrakopoulou, K Minichiello, FR Hirsch, PC Mack, LH Schwartz, E Vokes, S Ramalingam, N Leighl, J Bradley, J Miao, J Moon, L Highleyman, C Miwa, ML LeBlanc, S Malik, VA Miller, EV Sigal, S Adam, D Wholley, C Sigman, B Smolich, CD Blanke, K Kelly, DR Gandara, RS HerbstFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.